Peter Boyle’s appointment as President of the International Prevention Research Institute, Lyon, France follows immediately on his tenure as Director of the International Agency for Research on Cancer (IARC/WHO). From 1991-2004 he was Director of the Division of Epidemiology and Biostatistics at the Institute of Oncology in Milan, Italy. Prior to that he held posts as Senior Scientist at IARC, Assistant Professor in Epidemiology and Biostatistics at Harvard School of Public Health and the Dana-Farber Cancer Institute (Boston, United States), the West of Scotland Cancer Surveillance Unit (Glasgow, United Kingdom) and the Department of Medicine at Glasgow University.
Professor Boyle is the inaugural Director of the University of Strathclyde Institute of Global Public Health at iPRI, which is situated in Lyon and Glasgow. He is Professor of Global Public Health at the University of Strathclyde and currently holds Honorary or Visiting Professorships at Glasgow University and Yale University. He is founder and President of the World Prevention Alliance, a non-governmental organisation committed to prevention research and actions in lower income countries.
Peter Boyle’s research interests lie in disease prevention and translational research in its broadest sense, from translating cutting-edge scientific discovery into new approaches to treatment to translating information about risk factors into changes in population behaviour. He led the EUROCAN+PLUS project which developed priorities for coordination of cancer research in Europe and was Editor of the World Cancer Report 2008 and the State of Oncology 2013 which highlighted the growing global cancer crisis. The recent publication of State of Oncology in Africa 2015 and the accompanying film Cancer is … Attacking Africa, highlight the need for action against chronic disease in low-resource countries.
Peter Boyle has previously been a Member of the European Cancer Advisory Board and worked as the scientific advisor to the European Commission on the European Tobacco Contents Directive which was voted into law in 2002. He was also responsible for the revisions of the European Code Against Cancer.
Peter Boyle has been awarded the Knight’s Cross of Order of Merit of the Republic of Poland; Fellowship of the Royal Society of Edinburgh; Honorary Membership in the European Society for Therapeutic Radiology and Oncology (ESTRO), the Hungarian Oncological Association and the Argentine Medical Association; Fellowship of the Royal College of Physicians and Surgeons (Glasgow); Fellowship of the Royal College of Physicians (Edinburgh); Honorary Fellowship of the Royal College of Physicians of Ireland; Fellowship of the Academy of Medical Sciences (United Kingdom); Membership of the European Cancer Academy; Membership of Academia Europea; and Honorary Membership of the Hungarian Academy of Science. He has been awarded honorary doctorates by the Universities of Aberdeen (DSc) and Dundee (LlD).